🔗 Share this article

The top legal official in Texas Paxton is taking legal action against the producers of acetaminophen, alleging the firms hid potential risks that the drug posed to pediatric neurological development.

The court filing comes thirty days after President Donald Trump publicized an unsubstantiated connection between consuming Tylenol - alternatively called paracetamol - while pregnant and autism spectrum disorder in offspring.

Paxton is filing suit against Johnson & Johnson, which formerly manufactured the medication, the exclusive pain medication suggested for expectant mothers, and Kenvue, which presently makes it.

In a declaration, he claimed they "betrayed America by gaining financially from discomfort and marketing drugs without regard for the dangers."

The manufacturer says there is insufficient reliable data tying acetaminophen to autism.

"These corporations deceived for years, deliberately risking millions to increase profits," Paxton, a Republican, declared.

The manufacturer said in a statement that it was "very worried by the spread of false claims on the reliability of paracetamol and the potential impact that could have on the health of American women and children."

On its website, the company also said it had "regularly reviewed the applicable studies and there is insufficient valid information that shows a proven link between taking paracetamol and autism."

Groups acting on behalf of medical professionals and health professionals share this view.

ACOG has stated acetaminophen - the main ingredient in acetaminophen - is one of the few options for pregnant women to address discomfort and fever, which can pose significant medical dangers if not addressed.

"In over twenty years of studies on the use of acetaminophen in pregnancy, not a single reputable study has conclusively proven that the use of paracetamol in any trimester of pregnancy results in brain development issues in young ones," the group stated.

The court filing references latest statements from the Trump administration in claiming the drug is potentially dangerous.

Last month, Trump raised alarms from public health officials when he instructed pregnant women to "resist strongly" not to use acetaminophen when ill.

The US Food and Drug Administration then released a statement that medical professionals should contemplate reducing the consumption of acetaminophen, while also declaring that "a causal relationship" between the medication and autism in young ones has not been proven.

The Health Department head Robert F Kennedy Jr, who supervises the FDA, had pledged in April to undertake "extensive scientific investigation" that would determine the source of autism spectrum disorder in a limited time.

But authorities cautioned that discovering a unique factor of autism - considered by experts to be the outcome of a intricate combination of inherited and environmental factors - would not be simple.

Autism spectrum disorder is a form of permanent neurological difference and disability that affects how people perceive and relate to the world, and is diagnosed using doctors' observations.

In his legal document, the attorney general - aligned with the former president who is seeking federal office - alleges the manufacturer and J&J "deliberately disregarded and tried to quiet the research" around paracetamol and autism spectrum disorder.

The case attempts to require the firms "destroy any promotional materials" that asserts Tylenol is secure for women during pregnancy.

The Texas lawsuit parallels the grievances of a assembly of guardians of children with autism and ADHD who took legal action against the makers of Tylenol in recently.

Judicial authorities rejected the case, declaring studies from the parents' expert witnesses was not conclusive.